Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Studies yield promising data for Verigene Blood Culture Tests
December 2015
EDIT CONNECT

SHARING OPTIONS:

NORTHBROOK, Ill.—Nanosphere Inc. recently announced that new clinical data for its Verigene Gram-Positive (BC-GP) and Gram-Negative (BC-GN) Blood Culture Tests for rapid sepsis diagnostics were presented at the 55th Interscience Conference on Antimicrobial Agents and Chemotherapy. The data came from five studies, four of which included an analysis of the impact on patient outcomes. The results of the studies demonstrated a reduction in patients’ length of stay in the hospital or ICU, reduction in time to identify the organism and reduction in time to optimal therapy; in one study, the use of these tests together with antimicrobial stewardship team intervention led to reductions of three days, 25 hours and 32 hours in those criteria respectively. In another study, BC-GN was shown to have a positive predictive value of 100 percent for both bacterial identification and resistance gene detection, and a negative predictive value of 97 percent for resistance gene detection.
 
Code:

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.